Welcome

Hengrui Medicine (600276): PD-1 monoclonal antibody for esophageal cancer stage III clinical trials has reached the endpoint indication development progress

Hengrui Medicine (600276): PD-1 monoclonal antibody for esophageal cancer stage III clinical trials has reached the endpoint indication development progress In the evening of July 8th, Hengrui Pharmaceutical announced that the company’s Phase III clinical trial (ESCORT) of Carrelizumab in the second-line treatment of advanced esophageal squamous cell carcinoma reached the main endpoint.Researcher’s choice of […]

UFIDA (600588): Cloud and localization accelerate Huawei’s cooperation worth looking forward to

UFIDA (600588): Cloud and localization accelerate Huawei’s cooperation worth looking forward to The company has a long history of cooperation with Huawei. Kunpeng plans to reach a new level. On July 23, 2019, the Huawei Kunpeng Computing Industry Development Summit was held on the Beijing Stock Exchange. The company became the first batch of Huawei’s […]

Donghua Energy (002221): PDH spread rebounded, single quarter results hit record high

Donghua Energy (002221): PDH spread rebounded, single quarter results hit record high Event: The company released the third quarter report of 2019, and the company achieved operating income of 371 in the first three quarters. 580,000 yuan, an increase of 7 in ten years. 73%, achieving net profit attributable to shareholders of listed companies. 10,000 […]

China Great Wall (000066) major events quick review: re-acquisition of CEC quality assets layout industrial control independent controllable

China Great Wall (000066) major events quick review: re-acquisition of CEC quality assets layout industrial control independent controllable Event: The company announced on December 1 that its wholly-owned subsidiary, Sheng Feifan, intends to sign a “share transfer contract” with the Electronic Sixth Institute on the acquisition of the 100% distribution of the Zhengzhou Rail Transit […]

Jinjiang Co., Ltd. (600754) Interim Review: Strong store openings helped boost performance; same-store occupancy rate declines narrowed

Jinjiang Co., Ltd. (600754) Interim Review: Strong store openings helped boost performance; same-store occupancy rate declines narrowed Event: Jinjiang Co., Ltd. released its 2019 Interim Report and the company’s revenue in 19H1 was 71.4.3 billion / + 2.93%, net profit attributable to mother 5.6.8 billion / + 12.78%, net of non-attributed net profit3.5.8 billion / […]

Yili (600887): Third quarter revenue growth improved quarter-on-quarter, profit margin steadily increased

Yili (600887): Third quarter revenue growth improved quarter-on-quarter, profit margin steadily increased Event description Yili shares disclosed the 2019 third quarter report, the main content is as follows: the first three quarters of 2019 achieved total operating income of 686. 77 ppm, an increase of 11 in ten years. 98%, net profit attributable to mother […]

Zhongjia Bochuang (000889): Horizontal expansion of interest-bearing business, company performance expected to grow steadily

Zhongjia Bochuang (000889): Horizontal expansion of interest-bearing business, company performance expected to grow steadily The company successfully transformed the field of information transmission. Zhongjia Bochuang is a holding company. Its main businesses are intelligent information transmission, communication network maintenance, and financial service outsourcing. The main business operators are wholly-owned subsidiaries Mandao Technology, Changshi Communication and […]